Autonomix Medical, Inc.

AMIX Nasdaq CIK: 0001617867

Company Information

Industry Surgical & Medical Instruments & Apparatus
SIC Code 3841
Entity Type operating
SEC Category Non-accelerated filerSmaller reporting companyEmerging growth company
State of Incorporation DE
Business Address 21 WATERWAY AVENUE, SUITE 300, THE WOODLANDS, TX, 77380
Mailing Address 21 WATERWAY AVENUE, SUITE 300, THE WOODLANDS, TX, 77380
Phone 832-277-7816
Fiscal Year End 0331
EIN 471607810

Recent SEC Filings

Form Type Date Filed Document
10-Q Quarterly financial report February 11, 2026 View on SEC
8-K Current report of material events January 16, 2026 View on SEC
8-K Current report of material events January 9, 2026 View on SEC
S-3 Shelf registration for future offerings November 26, 2025 View on SEC
8-K Current report of material events November 19, 2025 View on SEC
10-Q Quarterly financial report November 12, 2025 View on SEC
8-K Current report of material events November 3, 2025 View on SEC
S-1 IPO registration statement September 23, 2025 View on SEC
DEF 14A Definitive proxy statement September 12, 2025 View on SEC
S-1/A IPO registration amendment September 3, 2025 View on SEC

Material Events

8-K Other January 16, 2026
High Impact
  • Successful completion of pivotal Phase 3 clinical trial for NeuroSense device, showing statistically significant efficacy and a strong safety profile.
  • NeuroSense is an innovative, non-invasive diagnostic tool for early-stage neurological disorders, offering a less invasive alternative to current methods.
View Analysis

Related Companies

Companies in the same industry (SIC: 3841)

Investor Resources

Learn more about SEC filings and how to research public companies.

Important Disclaimer

This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.